Page 169 - Technology Platform News Today

In this article, we discuss 10 fintech stocks getting hammered amid economic weakness.

In 2018, one of Austria’s largest construction companies sought out a solution to simply digitize its paper processes. What it did next would revolutionize the construction industry.

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

REGENXBIO Inc. (NASDAQ:RGNX – Get Rating) has received a consensus rating of “Moderate Buy” from the eleven analysts that are covering the company, Marketbeat.com reports. Four investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. The average 1 year price target among brokers that […]

ADELAIDE, AUS, July 20, 2022 - (ACN Newswire) - TrialWire(TM) Technology Platform, the most secure and rapid digital patient recruitment Platform for

TrialWire Technology Platform Rolls Out World First SMS/Text Patient Contact System Across all Studies Globally

/PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical-stage radiopharmaceutical company developing next-generation products to address the...

CALIFORNIA, July 19, 2022 - EMQ Technologies, the world’s leading provider of open-source IoT data infrastructure, today announced it had joined SAP’s Strategic Alliance for Sustainable Development and Practice with IBM, Deloitte, and other global partners...

Strs Ohio increased its stake in shares of REGENXBIO Inc. (NASDAQ:RGNX – Get Rating) by 177.8% in the 1st quarter, HoldingsChannel reports. The firm owned 17,500 shares of the biotechnology company’s stock after buying an additional 11,200 shares during the quarter. Strs Ohio’s holdings in REGENXBIO were worth $580,000 at the end of the most […]

TrialWire Technology Platform Announces Success-based Patient Recruitment Plan